Sarah Elkourashy: Diagnostic Challenges and Management Strategies for Maternal–Fetal Outcomes in TTP
Sarah Elkourashy, Consultant in Clinical Hematology and BMT at Hamad Medical Corporation, Assistant professor of clinical medicine at Weill Cornell Medicine-Qatar, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Journal of International Medical Research, adding:
”Thrombotic Thrombocytopenic Purpura (TTP) in pregnancy is a rare but critical hematologic emergency that requires rapid diagnosis and immediate intervention.
It often presents with thrombocytopenia and microangiopathic hemolytic anemia (MAHA) and can be challenging to distinguish from other pregnancy-related MAHA such as preeclampsia or HELLP syndrome.
Early recognition is essential, as delays in treatment can significantly impact maternal and fetal outcomes.
Plasma exchange remains the cornerstone of therapy, alongside immunosuppression.
A multidisciplinary approach is key to optimizing care.
Raising awareness of TTP in pregnancy is crucial to ensure timely management and improved outcomes.
This work highlights key challenges in diagnosis, especially in differentiating TTP from other pregnancy-related thrombotic microangiopathies, as well as current approaches to management aimed at improving both maternal and fetal outcomes.”
Title: Thrombotic thrombocytopenic purpura in pregnancy: Lessons from a case series of three patients
Authors: Sarah A. Elkourashy, Tamader Mashhadi, Amna Al-Kuwari, Sara Al-Abdulla, Gamal Sayed
Stay updated on all scientific advances with Hemostasis Today.
-
May 24, 2026, 04:11Ayah Ghazi Al-Qasrawi: How Should Sepsis-Induced DIC Be Managed in Patients Receiving Thienopyridines
-
May 24, 2026, 04:05Kate Hayward:
-
May 24, 2026, 03:33Raghavendra Rao: Short-Term Outcomes of Combined EVLA and Foam Sclerotherapy
-
May 24, 2026, 03:33Lucia Mazzolai: Systemic Vascular Approach to Peripheral Artery Disease
-
May 24, 2026, 03:32Isaac Okello: Africa CDC Launches Continental Framework for Sickle Cell Disease
-
May 24, 2026, 03:32Karine Kocharian: Advancing Hemophilia Care Equity at the 79th World Health Assembly
-
May 24, 2026, 03:31Dima Shulkin: Emerging Biomarkers for Early Prediction of Sepsis-Induced Shock
-
May 24, 2026, 00:54Andreas Ejlegard: The Promise of Smarter Antithrombotic Therapy with Cereno Scientific
-
May 24, 2026, 00:43Patient Advocacy and Clinical Excellence United at the European Certificate in Clinical Haemostasis – EHC